Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
Clinical trial NCT00616005 · COMPLETED
Trial details
- NCT number
- NCT00616005
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2007-07-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.